Treace Medical Concepts, Inc.
TMCITreace Medical Concepts is a medical technology company focused on advancing the standard of care for surgical management of bunion and midfoot deformities.
Earnings
Next report
Aug 7, 2026 (In 1 week)Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Treace Medical Concepts is a medical technology company focused on advancing the standard of care for surgical management of bunion and midfoot deformities. The company's core value proposition is its patented 3D correction technology, which addresses the root cause of deformities across three anatomic dimensions rather than just two. Their systems are designed to improve clinical outcomes, reduce recurrence rates, and allow for faster patient return to weight-bearing activities.
A pioneer and leader in 3D bunion correction, holding a significant patent portfolio and a specialized direct sales force focused exclusively on foot and ankle deformities.
Questions, answered.
- What is Treace Medical Concepts, Inc.'s market cap?
- Treace Medical Concepts, Inc. (TMCI) has a market capitalization of $264.7M and trades on NASDAQ.
- What is Treace Medical Concepts, Inc.'s revenue and profitability?
- Treace Medical Concepts, Inc. generated $207.3M in trailing twelve-month revenue with a net loss of $61.0M, representing a net margin of -29.4%. Gross margin stands at 79.7%, with free cash flow of -$26.0M. These figures are based on the Q1 2026 filing.
- Who are Treace Medical Concepts, Inc.'s competitors?
- Treace Medical Concepts, Inc.'s key competitors include CONMED Corporation, Zimmer Biomet Holdings, Inc., Enovis Corporation, and others. These companies compete in similar markets and product categories.
- Where is Treace Medical Concepts, Inc. headquartered?
- Treace Medical Concepts, Inc. is headquartered in United States of America and employs approximately 227 people. It has been publicly traded since 2021.
